Zurcher Kantonalbank Zurich Cantonalbank Has $22.90 Million Holdings in Centene Co. (NYSE:CNC)

Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Centene Co. (NYSE:CNC) by 0.8% during the third quarter, Holdings Channel reports. The institutional investor owned 304,148 shares of the company’s stock after purchasing an additional 2,556 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Centene were worth $22,896,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Park Place Capital Corp raised its holdings in Centene by 1,190.0% during the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after acquiring an additional 357 shares in the last quarter. WR Wealth Planners LLC raised its stake in Centene by 41.4% in the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after buying an additional 137 shares during the period. Chris Bulman Inc acquired a new stake in shares of Centene in the second quarter valued at approximately $33,000. Riverview Trust Co boosted its stake in shares of Centene by 154.6% during the 2nd quarter. Riverview Trust Co now owns 527 shares of the company’s stock worth $35,000 after acquiring an additional 320 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. bought a new stake in Centene in the 2nd quarter valued at $36,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Centene from $82.00 to $87.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Sanford C. Bernstein lowered their price target on shares of Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a report on Wednesday, October 30th. Wells Fargo & Company reduced their price objective on Centene from $91.00 to $90.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Cantor Fitzgerald reissued an “overweight” rating and set a $90.00 price target on shares of Centene in a report on Tuesday, October 1st. Finally, Barclays decreased their price objective on Centene from $97.00 to $91.00 and set an “overweight” rating on the stock in a report on Tuesday, October 29th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $83.92.

Centene Stock Up 0.1 %

CNC stock opened at $60.01 on Friday. The company has a market cap of $30.30 billion, a PE ratio of 10.42, a price-to-earnings-growth ratio of 0.82 and a beta of 0.49. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64. Centene Co. has a 52 week low of $57.20 and a 52 week high of $81.42. The business has a 50-day simple moving average of $65.11 and a 200 day simple moving average of $69.93.

Insider Activity

In other news, CFO Andrew Lynn Asher acquired 17,200 shares of the stock in a transaction on Wednesday, November 13th. The stock was acquired at an average cost of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the transaction, the chief financial officer now directly owns 486,847 shares in the company, valued at approximately $28,305,284.58. This trade represents a 3.66 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Sarah London bought 4,117 shares of Centene stock in a transaction on Friday, November 8th. The stock was acquired at an average cost of $60.80 per share, for a total transaction of $250,313.60. Following the acquisition, the chief executive officer now owns 667,229 shares in the company, valued at approximately $40,567,523.20. This represents a 0.62 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 0.33% of the company’s stock.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.